APA citiranje

Wasserman, R. L., Melamed, I., Stein, M. R., Engl, W., Sharkhawy, M., Leibl, H., . . . Gelmont, D. (2016). Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency. J Clin Immunol.

Citação norma Chicago

Wasserman, Richard L., et al. "Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency." J Clin Immunol 2016.

MLA citiranje

Wasserman, Richard L., et al. "Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency." J Clin Immunol 2016.